A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)

Clinical trial NCT06992882 · RECRUITING

Trial details

NCT number: NCT06992882
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2025-07-08
Primary completion: 2028-06-08
Enrollment: 2306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.